The long-standing partnership between AIBN and Clarity Pharmaceuticals continues to thrive with the signing of a brand-new Supply Agreement for radionuclide, Copper-64.
Join us at our event Science: It’s good business for a conversation about how UQ can enable your success through next generation products and your future workforce.
A new facility for enzyme formulation and production has been opened, strengthening a collaboration between the Australian Institute for Bioengineering and Nanotechnology and industry partner Bioproton.
Researchers at the Australian Institute for Bioengineering and Nanotechnology are using nano-engineered oil droplets to target infectious diseases and cancer cells.
Leading American biotechnology company Amyris, Inc. and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland have signed a Memorandum of Understanding to support the development of a Queensland-based biotechnology industry using feedstock from local sugarcane.